Corvus Pharmaceuticals, Inc. — Director's Dealing 2016

Mar 22, 2016

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Corvus Pharmaceuticals, Inc. (CRVS)
CIK: 0001626971
Period of Report: 2016-03-22

Reporting Person: Verner Erik J. (V.P., Chemistry Research)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock, $0.0001 par value	63773	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$0.28	2025-06-30	Common Stock (50000)		Direct

Footnotes

F1: A portion of these shares is subject to a right of repurchase held by the Issuer.

F2: The underlying shares subject to the option vest and become exercisable as to twenty-five percent (25%) of the shares subject to the option vest one year measured from July 1, 2015 (the "Vesting Commencement Date") and the remaining shares subject to the option vest in 36 successive, equal monthly installments thereafter on each monthly anniversary of the Vesting Commencement Date, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.